COVID-19 Evidence & Reports
Primary research papers
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19?
Tile subhead - BMJ 10 Mar 2021
Read the paperDevelopment and validation of the ISARIC 4C Deterioration model
Tile subhead - Lancet Respiratory Medicine 11 Jan 2021
Read the paperSymptoms at presentation for patients admitted to hospital with Covid-19
Tile subhead - MedRxiv pre-prints 27 Oct 2020
Read the paperOutcomes of COVID-19 Related Hospitalization Among People With HIV in the ISARIC WHO CCP
Tile subhead - Clinical Infectious Diseases 23 Oct 2020
Read the paperRisk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO CCP
Tile subhead - BMJ 9 Sep 2020
Read the paperClinical characteristics of children and young people admitted to hospital with COVID-19 in UK
Tile subhead - BMJ 27 Aug 2020
Read the paperEvaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19
Tile subhead - BMC Medicine 24 May 2020
Read the paperFeatures of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO CCP
Tile subhead - BMJ 22 May 2020
Read the paperA Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Tile subhead - NEJM 7 May 2020
Read the paperEvidence briefs
An evidence-based framework for priority clinical research questions for COVID-19
Tile subhead - Journal of Global Health Jun 2020
Read the evidence briefScope, quality, and inclusivity of clinical guidelines produced early in the COVID-19 pandemic
Tile subhead - BMJ 26 May 2020
Read the evidence briefCurrent report
Report archive
In March 2020 ISARIC started aggregating data collected from their contributing sites with the aim to produce clinical data reports.
These have been produced using data from the ISARIC COVID-19 clinical data platform.
Thanks to the contributing partners, the submitted data continues to grow allowing for a better understanding of COVID-19.